Resultats globals: 3 registres trobats en 0.02 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
28 p, 397.3 KB EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) / Lam, Thomas B.L. (Aberdeen Royal Infirmary) ; MacLennan, Steven (University of Aberdeen) ; Willemse, Peter-Paul M. (University Medical Center Utrecht) ; Mason, Malcolm D. (Velindre Cancer Centre) ; Plass, Karin (EAU Guidelines Office) ; Shepherd, Robert (EAU Guidelines Office) ; Baanders, Ruud ; Bangma, Chris H. (Erasmus University Medical Centre) ; Bjartell, Anders (Lund University) ; Bossi, Alberto (Gustave Roussy Institute) ; Briers, Erik ; Briganti, Alberto (IRCCS Ospedale San Raffaele (Milà, Itàlia)) ; Buddingh, Karel T. (HagaZiekenhuis) ; Catto, James W.F. (Royal Hallamshire Hospital) ; Colecchia, Maurizio (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) ; Cox, Brett W. (Zucker School of Medicine) ; Cumberbatch, Marcus G. (University of Sheffield) ; Davies, Jeff ; Davis, Niall F. (Royal College of Surgeons in Ireland) ; De Santis, Maria (Charité University Hospital) ; Dell'Oglio, Paolo (ORSI Academy) ; Deschamps, André (Europa Uomo) ; Donaldson, James F. (Aberdeen Royal Infirmary) ; Egawa, Shin (Jikei University School of Medicine) ; Fankhauser, Christian D. (University of Zurich) ; Fanti, Stefano (University of Bologna) ; Fossati, Nicola (Scientific Institute and University Vita-Salute San Raffaele Hospital) ; Gandaglia, Giorgio (IRCCS Ospedale San Raffaele) ; Gillessen, Silke (University of Bern) ; Grivas, Nikolaos (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Gross, Tobias (University of Bern) ; Grummet, Jeremy P. (Monash University) ; Henry, Ann M. (St. James's University Hospital) ; Ingels, Alexandre (Henri Mondor Hospital) ; Irani, Jacques (University Hospital of Bicêtre-Paris Sud-Saclay University) ; Lardas, Michael (Department of Reconstructive Urology and Surgical Andrology) ; Liew, Matthew (Wigan and Leigh NHS Foundation Trust) ; Lin, Daniel W. (University of Washington) ; Moris, Lisa (KU Leuven) ; Omar, Muhammad Imran (University of Aberdeen) ; Pang, Karl H. (University of Sheffield) ; Paterson, Catherine C. (Robert Gordon University) ; Renard-Penna, Raphaële (Sorbonne Université) ; Ribal, María J. (Hospital Clínic i Provincial de Barcelona) ; Roobol, M.J. (Erasmus University Medical Centre) ; Rouprêt, Morgan (Sorbonne Université) ; Rouvière, Olivier (Université de Lyon) ; Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Richenberg, Jonathan (Royal Sussex County Hospital Brighton and Brighton and Sussex Medical School) ; Schoots, Ivo G. (Erasmus University Medical Center) ; Sedelaar, J.P.Michiel (Radboud University Medical Centre) ; Stricker, Phillip (Garvan Institute of Research) ; Tilki, Derya (University Hospital Hamburg-Eppendorf) ; Vahr Lauridsen, Susanne (Copenhagen University Hospital) ; van den Bergh, Roderick C.N. (St. Antonius Hospital) ; Van den Broeck, Thomas (University Hospitals Leuven (Bèlgica)) ; van der Kwast, Theodorus H. (Erasmus University Medical Center) ; van der Poel, Henk G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; van Leenders, Geert J.L.H. (Erasmus University Medical Center) ; Varma, Murali (University Hospital of Wales) ; Violette, Philippe D. (McMaster University (Canadà)) ; Wallis, Christopher J.D. (Vanderbilt University Medical Center) ; Wiegel, Thomas (University Hospital of Ulm (Alemanya)) ; Wilkinson, Karen (University College London Hospitals) ; Zattoni, Fabio (Academic Medical Centre Hospital) ; N'Dow, James M.O. (Aberdeen Royal Infirmary) ; Van Poppel, Hendrik (University Hospitals Leuven (Bèlgica)) ; Cornford, Philip (Royal Liverpool and Broadgreen Hospitals NHS Trust) ; Mottet, Nicolas (University Hospital Jean Monnet) ; Universitat Autònoma de Barcelona
There is uncertainty in deferred active treatment (DAT) programmes, regarding patient selection, follow-up and monitoring, reclassification, and which outcome measures should be prioritised. To develop consensus statements for all domains of DAT. [...]
2019 - 10.1016/j.eururo.2019.09.020
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 790-813  
2.
8 p, 841.5 KB Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma : A Randomized Phase 2 Study / Lindskog, M. (Department of Immunology. Genetics and Pathology. Uppsala University Hospital. Uppsala University) ; Laurell, Anna (Department of Oncology. Akademiska University Hospital) ; Kjellman, Anders (Department of Urology. CLINTEC. Karolinska University Hospital. Karolinska Institutet) ; Melichar, Bohuslav (Department of Urology and Urological Oncology. Wojewodzki Szpital Specjalistyczny im. Stefana Kardynała Wyszyńskiego) ; Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Zieliński, Henryk (Clinical Urology. Military Institute of Medicine) ; Villacampa, Felipe (Hospital Universitario 12 de Octubre (Madrid). Servicio de Urología) ; Bigot, Pierre (Department of Urology. Centre Hospitalier Universitaire d'Angers) ; Zoltan, Bajory (Szent-Györgyi Albert Klinikai Központ. Szegedi Tudomanyegyetem Altalanos Ovostudomanyi Kar Urologiai Klinika) ; Parikh, Omi (Rosemere Cancer Centre. Royal Preston Hospital) ; Vázquez Alba, David (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Jellvert, Åsa (Department of Oncology. Institute of Clinical Sciences. Sahlgrenska Academy. University of Gothenburg) ; Flaskó, Tibor (Department of Urology. Medical School. University of Debrecen) ; Gallardo, Eduard (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Ribal Caparrós, María José (Hospital Clínic i Provincial de Barcelona) ; Purkalne, Gunta (Oncology Clinic. Pauls Stradins Clinical University Hospital) ; Suenaert, Peter (Immunicum AB) ; Karlsson-Parra, Alex (Department of Immunology. Genetics and Pathology. Section of Clinical Immunology. Uppsala University) ; Ljungberg, Börje (Department of Surgical and Perioperative Sciences. Urology and Andrology. Umeå University) ; Universitat Autònoma de Barcelona
Background: The prognosis of patients with synchronous metastatic renal cell carcinoma (mRCC) is poor. Whereas single-agent tyrosine kinase inhibition (TKI) is clearly insufficient, the effects can be enhanced by combinations with immune checkpoint inhibitors. [...]
2022 - 10.1016/j.euros.2022.03.012
European Urology Open Science, Vol. 40 (june 2022) , p. 38-45  
3.
14 p, 17.4 MB P53 in Penile Squamous Cell Carcinoma : A Pattern-Based Immunohistochemical Framework with Molecular Correlation / Trias, Isabel (Hospital Clínic i Provincial de Barcelona) ; Saco, Adela (Hospital Clínic i Provincial de Barcelona) ; Marimon, Lorena (Hospital Clínic i Provincial de Barcelona) ; López del Campo, Ricardo (Hospital Clínic i Provincial de Barcelona) ; Manzotti, Carolina (Hospital Clínic i Provincial de Barcelona) ; Ordi, Oriol (Universitat de Barcelona) ; del Pino, Marta (Hospital Clínic i Provincial de Barcelona) ; Pérez, Francisco M. (Hospital Clínic i Provincial de Barcelona) ; Vega, Naiara (Hospital Clínic i Provincial de Barcelona) ; Alós, Silvia (Hospital Clínic i Provincial de Barcelona) ; Martínez, Antonio (Hospital Clínic i Provincial de Barcelona) ; Rodriguez-Carunchio, Leonardo (Hospital Clínic i Provincial de Barcelona) ; Reig, Oscar (Hospital Clínic i Provincial de Barcelona) ; Jares, Pedro (Hospital Clínic i Provincial de Barcelona) ; Teixidó, Cristina (Hospital Clínic i Provincial de Barcelona) ; Ajami, Tarek (Hospital Clínic i Provincial de Barcelona) ; Corral-Molina, Juan Manuel (Hospital Clínic i Provincial de Barcelona) ; Algaba, Ferran (Fundació Puigvert) ; Ribal, María J. (Hospital Clínic i Provincial de Barcelona) ; Ribera-Cortada, Inmaculada (Hospital Clínic i Provincial de Barcelona) ; Rakislova, Natalia (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Penile squamous cell carcinomas harbouring mutations of TP53 have an increased risk of lymph node metastases and an impaired prognosis, but the mutational analysis of the TP53 gene is not available in many pathology laboratories. [...]
2023 - 10.3390/cancers15102719
Cancers, Vol. 15 (may 2023)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.